Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 06, 2021 3:36pm
108 Views
Post# 33337758

RE:RE:Why choose IPF when liver and kidney so big?

RE:RE:Why choose IPF when liver and kidney so big?

Stop the BS. You obviously didn't read the Piper Sandler report but still post here 30 times a day. Read something and you might have a tad of credibility. Piper report was based on IPF and gave about $3 per share for Plasma division. 

realstocky wrote:

thomvest owns 70% of all shares, i'll give u this... they are sharks! But these sharks will want their shares up high, dont forget they paid 15$+, they are trading +-7$ on friday after hours... 8,3M shares traded, cant wait to see if tv and piper gat some...the drugs, including pbi4050 have huge potential, and i dont put b.s. NR beyond tv....and piper, both geniuses issuing NRs days prior the known incoming FDA decision... tv "suspending 1 trial", door left open....and piper with a price target that is  5 days old that doesnt mean squat anymore with the green light from the FDA... both these NRs weaken the sp prior the FDA ok friday!

 

all games...  all for $$$... piper backed lmnl in the past.....and im sur lmnl knew it looked good on the FDA, and very probably pbi4050 (that indication, we have several ongoing) will be back online soon under x reason.

I suggest we ride it up, but careful of smoke and mirrors. SP is cheap with huge potential, the big fish want your shares.

 

from camo:
 

 

tHANKS to the FDA green light yesterday, the priority voucher will be sold on market, its value is of 80M$ to 120M$ u.s. Lets go with 100M$....lmnl gets 70%, +5M$ + 17M$, all u.s.$....so lmnl gets 70M+17M+5M= 92M$ u.s.... about 100M$ canadian... market cap on NR was about ...100M$ as well so i see major push next days.

at least 10$+ next trading days (market cap is extremely low)

 

Congrats to those that bought early.


<< Previous
Bullboard Posts
Next >>